Summer G. Frank-Pearce, PhD, MPH, is an Assistant Professor of Research in Biostatistics in the Department of Biostatistics and Epidemiology, and a member of the Biostatistics and Research Design Shared Resource (BRD SR) for the Stephenson Cancer Center. She earned a PhD from the University of Oklahoma Health Sciences Center in 2016 and has worked with Oklahoma Tobacco Research Center since 2015.
Frank-Pearce has been involved in the management, analysis and interpretation of clinical research and population health data from pilot studies assessing feasibility/effectiveness to individual and group randomized trials. She has engaged in projects that address a variety of health behaviors, disparities, and outcomes. Frank-Pearce provides statistical support in the design, development, analysis, and dissemination of clinical and health research for the HPRC faculty. Her statistical research interests include multilevel/mixed model methods, longitudinal data analysis with time-varying covariates, and missing data problems.
Education:
Degree-Granting Institutions
The University of Oklahoma, Oklahoma City, OK, Ph.D., 2016, Biostatistics
The University of Oklahoma, Oklahoma City, OK, MPH, 2008, Biostatistics
The University of Oklahoma, Norman, OK, B.S., 2000, Zoology
Funding:
Current Funding:
Kendzor, D. E. (Principal Investigator), Ahluwalia, J. (Co-Principal Investigator), Businelle, M. S. (Co-Investigator), Frank-Pearce, S. G. (Co-Investigator), Baranskaya, I. V. (Co-Investigator), Sifat, M. (Co-Investigator)*, Hébert, E. T. (Co-Investigator), "Randomized Factorial Trial of Varenicline with Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation," Sponsored by National Cancer Institute, Federal
Grant/Contract Number: R01CA298165
Total Direct Costs: $2,229,393.00
December 1, 2024 - November 30, 2026
Kendzor, D. E. (Principal Investigator), 30% Effort, Businelle, M. S. (Co-Investigator), Vidrine, D. J. (Co-Investigator), Pearce-Frank, S. (Co-Investigator), Alexander, A. C. (Co-Investigator)*, Dallery, J. (Co-Investigator), Shih, Y.-C. (Co-Investigator), "Automated Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults," Sponsored by National Cancer Institute, Federal
Grant/Contract Number: R01CA251451
Total Direct Costs: $2,240,653.00
April 1, 2021 - March 31, 2026
Alexander, Adam (PI), Frank-Pearce, S. G. (Biostatistics Mentor) "HealthyCells: A Culturally-Tailored Smoking Cessation Smartphone Intervention for African Americans with Adjunctive Treatment for Sedentary Behavior"
K01 MD015295-01A1, NIMHHD
Total direct: $670,210
May 8, 2021 – January 1, 2026
Vogel, Erin (PI), Frank-Pearce, S. G. (Co-I/Biostatistician) "Identifying and addressing the effects of social media use on young adults’ e-cigarette use: A solutions-oriented approach"
K01 DA055073, NIDA
Total direct: $852,100
February 1, 2023 – January 1, 2028
Kendzor, Darla (PI), Frank-Pearce, S. G. (Co-I/Biostatistician)
"Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults"
R01CA251451, NIH/NCI
Total direct: $2,704,463
April 1, 2021 – March 31, 2026
Bui, Thanh (PI), Frank-Pearce, S. G. (Co-I/Biostatistician)
"Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Support Laos)"
R21 CA253600-01 (R21/R33, NCI/FIC)
Total direct: $843,863
September 01, 2020 – August 30, 2025
Previous Funding:
Businelle, M. I. (Principal Investigator), Frank-Pearce, S. G. (Biostatistician)
"Smartphone Based Smoking Cessation Intervention for Socioeconomically Disadvantaged Adults"
Sponsored by the National Cancer Institute, Federal Grant/Contract Number: R01CA221819
Current Funding (Total Costs per Year): $543,718.00
Total Direct Costs: $1,874,8903.00
February 1, 2019 - January 31, 2024
Vidrine, J. I. (Principal Investigator), Frank, S. G. (Biostatistician), "Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare System"
Sponsored by the National Cancer Institute, Federal Grant/Contract Number: R01CA172786
Current Funding (Total Costs per Year): $353,309.00
Total Direct Costs: $1,766,543.00
May 12, 2014 - August 30, 2020
Mannel, Robert (PI), Frank-Pearce, S. G. (Biostatistician, 10% effort)
"Mobile Health Study and Chemoprophylaxis for Preventing Severe Illness from COVID-19 in Cancer"
Administrative Supplement to P30CA225520, NIH/NCI
Total direct: $250,000
June 1, 2020 – May 31, 2021
Select Publications:
Ogunsanya ME, Frank-Pearce SG, Chen S, Sifat M, Cohn AM, Businelle MS, Kendzor DE. The influence of sociodemographic, tobacco use, and mental health characteristics on treatment adherence among adults enrolled in a community-based tobacco cessation program. Addict Behav Rep. 2024 Oct 19;20:100568. doi: 10.1016/j.abrep.2024.100568. PMID: 39559172; PMCID: PMC11570729.
Kendzor, DE, Davie, M, Chen, M, Hart, J, Frank-Pearce, SG, Doescher, MP, Alexander, AC, Businelle, MS, Ogunsanya, ME, Sifat, MS, Boozary, LK (in press). Incentivizing Tobacco Helpline Engagement in Persistent Poverty Counties: A Randomized Trial. American Journal of Preventive Medicine.
Sedani, AE, Frank-Pearce, SG, Beebe, LA, Campbell, JE, Peck, JD, Chou, AF, Cohn, AM. (In press). Cannabis Use and Cigarette Discontinuation Among Adult Cigarette Users in the Population Assessment of Tobacco and Health (PATH) Study. Nicotine Tob Res. 2024 Aug 23:ntae202. doi: 10.1093/ntr/ntae202. Epub ahead of print. PMID: 39178320..
Warner, EA, Azizoddin, D, Frank-Pearce, S, Ford, L, Bradley, D, Cohn, A, Businelle, M, Spicer, P, Appleseth, H, McQuoid, J. “It frees your body from that pain thought”: A mixed methods exploration of patterns, contexts, and experiences of cannabis use for pain in rural communities. Journal of Pain. The Journal of Pain, Volume 25, Issue 11, 104636.
Sedani, AE, Frank-Pearce, SG, Chen, S, Peck, JD, Campbell, JE, Chou, AF, Beebe, LA. (In press). Impact of Quitline Services on Tobacco Cessation: An Application of Modern Epidemiological Methods. Am J Epidemiol. 2024 Aug 21:kwae292. doi: 10.1093/aje/kwae292. Epub ahead of print. PMID: 39168831.
Kendzor, DE, Businelle, MS, Frank-Pearce, SG, Waring, JJC, Chen, S, Hébert, ET, Swartz, MD, Alexander, AC, Sifat, MS, Boozary, LK, Wetter, DW. Small financial incentives for smoking cessation among socioeconomically disadvantaged adults: A randomized controlled trial. JAMA Network Open, 7(7), e2418821. DOI: 10.1001/jamanetworkopen.2024.18821
Businelle, MS, Benson, L, Hébert, ET, Neil, J, Kendzor, DE, Frank-Pearce, S, Kezbers, KM, Vidrine, D, Gaur, A. Project phoenix: Pilot randomized controlled trial of a smartphone-delivered intervention for people who are not ready to quit smoking. Drug Alcohol Depend. 2024 May 31;260:111351. doi: 10.1016/j.drugalcdep.2024.111351. Epub ahead of print. PMID: 38838477; PMCID: PMC11179962
Ulm, C, Chen, S, Fleshman, B, Benson, L, Kendzor, DE, Frank-Pearce, S, Neil, JM, Vidrine, D, Businelle, MS. Smartphone-Based Survey and Message Compliance in Adults Initially Unready to Quit Smoking: Secondary Analysis of a Randomized Controlled Trial JMIR Form Res 2024;8:e56003 doi: 10.2196/56003 PMID: 38848557
Huynh N, Kendzor DE, Ra CK, Frank-Pearce SG, Alexander AC, Businelle MS, Samson DR. The association of sleep with physical and mental health among people experiencing homelessness. Sleep Health. 2024 Feb;10(1):48-53. doi: 10.1016/j.sleh.2023.10.004. Epub 2023 Nov 21. PMID: 37989628
Sifat M, Hébert ET, Ahluwalia JS, Businelle MS, Waring JJC, Frank-Pearce SG, Bryer C, Benson L, Madison S, Planas LG, Baranskaya I, Kendzor DE Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial JMIR Form Res 2023;7:e48857 doi: 10.2196/48857 PMID: 37889541 PMCID: 10638635
Huff KA, Braun A, Salvaggio MR, McGough P, Frank-Pearce SG, Kendzor DE, Bui TC. Promoting HPV Vaccination in People with HIV: Factors to Consider. Int J Environ Res Public Health. 2023 Mar 31;20(7):5345. doi: 10.3390/ijerph20075345. PMID: 37047959; PMCID: PMC10094493
Bui TC, Hoogland CE, Chhea C, Sopheab H, Ouk V, Samreth S, Hor B, Vidrine JI, Businelle MS, Shih YCT, Sutton SK, Jones SR, Shorey Fennell B, Cottrell-Daniels C, Frank-Pearce SG, Ngor C, Kulkarni S, Vidrine DJ. Ending tobacco use through interactive tailored messaging for Cambodian people with HIV (Project EndIT): Protocol for a randomized controlled trial. JMIR Research Protocols (in press). doi: 10.2196/48923
Vidrine, JI, Sutton, SK, Wetter, DW, Shih, YCT, Ramondetta, LM, Elting, LS, Walker, JL, Smith, KM, Frank-Pearce, SG, Li, Y, Jones, SR, Kendzor, DE, Simmons, VN & Vidrine, DJ (Accepted to Clinical Oncology 2/6/2023). Efficacy of a smoking cessation intervention for survivors of cervical intraepithelial neoplasia or cervical cancer: A randomized controlled trial
Benson L, Ra CK, Hébert ET, Kendzor DE, Oliver JA, Frank-Pearce SG, Neil JM, Businelle MS. Quit Stage and Intervention Type Differences in the Momentary Within-Person Association Between Negative Affect and Smoking Urges. Front Digit Health. 2022 Mar 29;4:864003. doi: 10.3389/fdgth.2022.864003. PMID: 35425934; PMCID: PMC9001839
Kendzor DE, Businelle MS, Vidrine DJ, Frank-Pearce SG, Shih YT, Dallery J, Alexander AC, Boozary LK, Waring JJC, Ehlke SJ. Mobile contingency management for smoking cessation among socioeconomically disadvantaged adults: Protocol for a randomized trial. Contemporary Clinical Trials. 2022 Mar;114:106701. DOI: 10.1016/j.cct.2022.106701. PMID: 35114409
More research publications